RORA and intestinal neoplasm: Deletion of RORα in adaptive T cells did not affect intestinal tumor burden, and exogenous IL-25 treatment in ILC2-replete and ILC2-deplete mice showed that ILC2s are essential for IL-25-mediated intestinal tumorigenesis.